Predicting isocitrate dehydrogenase genotype in malignant glioma with multimodality imaging markers.
Phase 0 trial of AZD1775 in patients with first-recurrence glioblastoma. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a full text component.
Changes in marker genotype (ROH)-based inbreeding coefficients in apple parental population. (IMAGE)
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Adial Pharmaceuticals has announced the issuance of patent number 12,226,401, which enhances their genetic-based approach for treating alcohol and opioid use disorders. This new patent focuses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results